Cargando…

Plasma concentration of atorvastatin metabolites correlates with low‐density lipoprotein cholesterol reduction in patients with coronary heart disease

In this exploratory study from a randomized double‐blinded crossover trial including 70 patients with coronary heart disease and self‐perceived muscular side effects of statins, we aimed to determine the relationship between low‐density lipoprotein cholesterol (LDL‐C) reduction and atorvastatin meta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sverre, E., Munkhaugen, J., Kristiansen, O., Weedon‐Fekjær, H., Peersen, K., Gjertsen, E., Gullestad, L., Bergan, S., Husebye, E., Vethe, N. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131217/ https://www.ncbi.nlm.nih.gov/pubmed/37186070 http://dx.doi.org/10.1002/prp2.1089

Ejemplares similares

Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population
por: Sverre, E., et al.
Publicado: (2020)

Effect of atorvastatin on muscle symptoms in coronary heart disease patients with self-perceived statin muscle side effects: a randomized, double-blinded crossover trial
por: Kristiansen, Oscar, et al.
Publicado: (2020)

A novel direct method to determine adherence to atorvastatin therapy in patients with coronary heart disease
por: Kristiansen, Oscar, et al.
Publicado: (2019)

Unfavourable risk factor control after coronary events in routine clinical practice
por: Sverre, Elise, et al.
Publicado: (2017)

Clinical and psychological factors in coronary heart disease patients with statin associated muscle side-effects
por: Peersen, Kari, et al.
Publicado: (2021)

Medical and sociodemographic factors predict persistent smoking after coronary events
por: Sverre, Elise, et al.
Publicado: (2017)

Relationship of High‐Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin
por: Ong, Kwok Leung, et al.
Publicado: (2018)

Insomnia as a predictor of recurrent cardiovascular events in patients with coronary heart disease
por: Frøjd, Lars Aastebøl, et al.
Publicado: (2022)

Risk of recurrent cardiovascular events in coronary artery disease patients with Type D personality
por: Torgersen, Kristin Stensland, et al.
Publicado: (2023)

Reproducibility of an extensive self-report questionnaire used in secondary coronary prevention
por: Peersen, Kari, et al.
Publicado: (2017)

Comparative study of the effect of atorvastatin and fenofibrate on high-density lipoprotein cholesterol levels in patients with type 2 diabetes
por: Najafipour, Mostafa, et al.
Publicado: (2018)

The N‐Acetylgalactosamine‐conjugated small interfering RNA inclisiran can be coadministered safely with atorvastatin in cynomolgus monkeys resulting in additive low‐density lipoprotein cholesterol reductions
por: Lehoux, Dario, et al.
Publicado: (2023)

Association of the low-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio and concentrations of plasma lipids with high-density lipoprotein subclass distribution in the Chinese population
por: Tian, Li, et al.
Publicado: (2010)

Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction
por: Henry, Courtney A, et al.
Publicado: (2016)

Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study
por: Munkhaugen, John, et al.
Publicado: (2018)

Flexible Initial Dosing of Atorvastatin Based Upon Initial Low-Density Lipoprotein Cholesterol Levels in Type 2 Diabetic Patients
Publicado: (2008)

Factors influencing drug switching and changes in low-density lipoprotein-cholesterol levels with atorvastatin: a real-world observational study
por: Lim, Yu-Cheol, et al.
Publicado: (2023)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Comparison of low-density lipoprotein cholesterol/high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol for the prediction of thin-cap fibroatheroma determined by intravascular optical coherence tomography
por: WANG, Yao, et al.
Publicado: (2020)

Total cholesterol/high-density lipoprotein cholesterol and low-density lipoprotein cholesterol/high-density lipoprotein cholesterol as predictors of coronary artery calcification assessed by multidetector computed tomography coronary angiography
por: Elsadek Seaoud, Elshaimaa Aly M., et al.
Publicado: (2022)

Association of the Low-density Lipoprotein Cholesterol/High-density Lipoprotein Cholesterol Ratio with Glecaprevir-pibrentasvir Treatment
por: Akutsu, Noriyuki, et al.
Publicado: (2021)

Assessment of serum levels of triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol in periodontitis patients
por: Penumarthy, Swati, et al.
Publicado: (2013)

Assessing the Accuracy of Estimated Lipoprotein(a) Cholesterol and Lipoprotein(a)‐Free Low‐Density Lipoprotein Cholesterol
por: Zheng, Weili, et al.
Publicado: (2022)

Triglycerides, total cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol in rats exposed to premium motor spirit fumes
por: Aberare, Ogbevire L., et al.
Publicado: (2011)

The association of financial incentives for low density lipoprotein cholesterol reduction with patient activation and motivation
por: Liu, Tianyu, et al.
Publicado: (2019)

Low Density Lipoprotein-Cholesterol/High Density Lipoprotein-Cholesterol Ratio Predicts Plaque Vulnerability in Patients With Stable Angina
por: Kim, Jeong Hun, et al.
Publicado: (2012)

Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction
por: Sigdel, Manoj, et al.
Publicado: (2012)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk
por: Sheng, Guotai, et al.
Publicado: (2022)

Low‐Density Lipoprotein Cholesterol Corrected for Lipoprotein(a) Cholesterol, Risk Thresholds, and Cardiovascular Events
por: Willeit, Peter, et al.
Publicado: (2020)

High‐Density Lipoprotein Cholesterol Concentration and Acute Kidney Injury After Cardiac Surgery
por: Smith, Loren E., et al.
Publicado: (2017)

Serum Low Density Lipoprotein Cholesterol Concentration Is Not Dependent on Cholesterol Synthesis and Absorption in Healthy Humans
por: Stellaard, Frans, et al.
Publicado: (2022)

Heated tobacco products and circulating high-density lipoprotein cholesterol concentrations
por: Hu, Huan, et al.
Publicado: (2022)

High-density lipoprotein cholesterol: How High
por: Rajagopal, G., et al.
Publicado: (2012)

The Role of High-Density Lipoprotein Cholesterol in 2022
por: Sirtori, Cesare R., et al.
Publicado: (2022)

Association between the Non-high-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio and the Risk of Coronary Artery Disease
por: You, Jiayin, et al.
Publicado: (2020)

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
por: Nurmohamed, Nick S, et al.
Publicado: (2021)

Risk assessment of metabolic syndrome in adolescents using the triglyceride/high-density lipoprotein cholesterol ratio and the total cholesterol/high-density lipoprotein cholesterol ratio
por: Chu, Shou-Yu, et al.
Publicado: (2019)

Effects of smoking cessation using varenicline on the serum concentrations of oxidized high-density lipoprotein: Comparison with high-density lipoprotein cholesterol
por: Umeda, Akira, et al.
Publicado: (2022)

The Association between the Triglyceride to High-density Lipoprotein Cholesterol Ratio and Low-density Lipoprotein Subclasses
por: Moriyama, Kengo
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vjfogelmmpdl9o2sm56sc76jjq